Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1965 Mar 13;1(5436):704–706.

To-day's Drugs

PMCID: PMC2166411  PMID: 14245212

Full text

PDF
704

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FLETCHER A. P., ALKJAERSIG N., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest. 1962 Apr;41:896–916. doi: 10.1172/JCI104546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FLETCHER A. P., BIEDERMAN O., MOORE D., ALKJAERSIG N., SHERRY S. ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES. J Clin Invest. 1964 Apr;43:681–695. doi: 10.1172/JCI104953. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES